Hatt M, Tixier F, Pierce L, Kinahan P, Cheze Le Rest C, Visvikis D. Characterization of PET/CT images using texture analysis: the past, the present… any future? Eur J Nucl Med Mol Imaging. 2017;44:151–65.
Cook G, Goh V. A role for FDG PET radiomics in personalized medicine. Semin Nucl Med. 2020;50:532–40.
Deleu A, Sathekge M Jr, Maes A, De Spiegeleer B, Sathekge M Sr, Van de Wiele C. Characterization of FDG PET images using texture analysis in tumors of the gastro-intestinal tract: a review. Biomedicines. 2020;8(9):304. https://doi.org/10.3390/biomedicines8090304.
Article PubMed Central Google Scholar
Orlhac F, Soussan M, Maisonobe J, Garcia C, Vanderlinden B, Buvat I. Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med. 2014;55:414–22.
Hatt M, Majdoub M, Vallières M, Tixier F, Cheze le Rest C, Groheux D, et al. 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med. 2015;56:38–44.
Babyak M. What you see may not be what you get: a brief, non-technical introduction to overfitting in regression-type models. Psychosom Med. 2004;66:411–21.
Peduzzi P, Concato J, Kemper E, Holford T, Feinstein A. A simulation study of number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–9.
Chalkidou A, O’Doherty M, Marsden P. False discovery rates in PET and CT studies with texture features: a systematic review. PLoS ONE. 2015. https://doi.org/10.1371/journal.pone0124165.
Article PubMed PubMed Central Google Scholar
Kiers H, Smilde A. A comparison of various methods for multivariate regression with collinear variables. Stat Methods Appl. 2007;16:193–228.
Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78(16):4786–9.
Zwanenburg A, Vallières M, Abdalah M, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high throughput images-based phenotyping. Radiology. 2020. https://doi.org/10.1148/radiol.2020191145.
Fornacon-Wood I, Mistry H, Ackermann C, Blackhall F, McPartlin A, Faivre-Finn C, et al. Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform. Eur Radiol. 2020;30:6241–50.
Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging. 2013;40:290–301.
Zasadby K, Kison P, Francis R, Wahl R. FDG-PET determination of metabolically active tumor volume and comparison with CT. Clin Positron Imaging. 1998;1:123–9.
Liao S, Penney B, Zhang H, Suzuki K, Pu Y. Prognostic value of the quantitative metabolic volumetric tumor burden on 18F-FDG PET/CT in stage IV nonsurgical small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2012;39:27–38.
Zhang H, Woblewski K, Appelbaum D, Pu Y. Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer. Int J Comput Assist Radiol Surg. 2012. https://doi.org/10.1007/s11548-012-0749-7.
Lasnon C, Enilorac B, Popotte H, Aide N. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs). EJNNMI Research. 2017;7:30.
Devriese J, Beels L, Maes A, Van de Wiele C, Pottel H. Impact of PET reconstruction protocols on quantification of lesions that fulfill the PERCIST inclusion criteria. EJNMM Phys. 2018;5(1):35. https://doi.org/10.1186/s40658-018-0235-6.
Tixier F, Le Reste C, Hatt M, Albarghach N, Pradier O, Metges J, et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med. 2011;52:369–78.
Orlhac F, Soussan M, Maisonobe J, Garcia C, Vanderlinden B, Buvat I. Tumor texture analysis in 18F-FDG PET: relationships between texture paramaters, histogram indices, standardized uptake values, metabolic volumes and total lesion glycolysis. J Nucl Med. 2014;55:414–22.
Orlhah F, Nioche C, Soussan M, Buvat I. Understanding changes in tumor texture indices in PET: a comparison between visual assessment and index values in simulated and patient data. J Nucl Med. 2017;58:387–92.
Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomographye (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project. J Thorac Oncol. 2008;3:6–12.
Lee M, Jung Y, Kim D, Lee S, Jung C, Kang S, et al. Prognostic value of SUVmax in breast cancer and comparative analyses of molecular subtypes: a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(31): e26745.
Ghooskhanei H, Treglia G, Sabouri G, Davoodi R, Sadeghi R. Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. Gynecol Oncol. 2014;132(3):669–76.
Hughes N, Mou T, O’Regan N, Murphy P, O’Sullivan J, Wolsztunski E, et al. Tumor heterogeneity measurements using (18F)FDG PET/CT shows prognostic value in patients with non-small cell lung cancer. Eur J Hybrid Imaging. 2018. https://doi.org/10.1186/s41824-018-0043-1.
van Gomez LO, Vicente A, Martinez A, Castrejon A, Londono G, Udias J, et al. Heterogeneity in (18F)fluorodeoxyglucose positron emission tomography of non-small cell lung carcinoma and its relationship to metabolic parameters and pathologic staging. Mol Imaging. 2014. https://doi.org/10.2310/7290.2014.00032.
Shafiq-ul-Hassan M, Latifi K, Zhang G, Ullah G, Gillies R, Moros E. Voxel size and gray level normalization of CT radiomic features in lung cancer. Sci Rep. 2018;8:10545. https://doi.org/10.1038/s41598-018-28895-9.
CAS Article PubMed PubMed Central Google Scholar
Welch M, McIntosh C, Haibe-Kains B, Milosevic M, Wee L, Dekker A, et al. Vulnerabilities of radiomic signature development: the need for safeguards. Radiother Oncol. 2019;130:2–9.
Fathinul F, Nordin A, Lau W. 18(F)FDG -PET/CT is a useful molecular marker in evaluating tumour agressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology. Cell Biochem Biophys. 2013;66:37–43.
Pantel A, Ackerman D, Lee S, Mankoff D, Gade T. Imaging cancer metabolism: underlying biology and emerging strategies. J Nucl Med. 2018;59:1340–9.
Riester M, Xu Q, Moreira A, Michor A, Zheng J, Michor F, Downey R. The Warburg effect: persistence of stem-cell metabolism in cancers as a failure of differentiation. Ann Oncol. 2018;29:264–70.
Lucia F, Visvikis D, Desseroit M, Miranda O, Malhaire J, Robin P, et al. Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. EJNNMI. 2018;45:768–86.
Sun Y, Qiao X, Jiang C, Liu S, Zhou Z. Texture analysis improves the value of pretreatment 18F-FDG PET/CT in predicting interim response of primary gastrointestinal diffuse large B-cell lymphoma. Contrast Media Mol Imaging. 2020. https://doi.org/10.1155/2020/2981585.
Article PubMed PubMed Central Google Scholar
Hatt M, Rixier F, Cheze le Rest C, Pradier O, Visvikis D. Robustness of intratumour 18F-FDG PET uptake heterogenity quantification for therapy response prediction in oesophageal carcinoma. EJNNMI. 2013;40:1662–71.
留言 (0)